Literature DB >> 10866833

Large-scale expression and thermodynamic characterization of a glutamate receptor agonist-binding domain.

D R Madden1, R Abele, A Andersson, K Keinänen.   

Abstract

The ionotropic glutamate receptors (GluR) are the primary mediators of excitatory synaptic transmission in the brain. GluR agonist binding has been localized to an extracellular domain whose core is homologous to the bacterial periplasmic binding proteins (PBP). We have established routine, baculovirus-mediated expression of a complete ligand-binding domain construct at the 10-L scale, yielding 10-40 milligrams of purified protein. This construct contains peptides that lie outside the PBP-homologous core and that connect the domain core to the transmembrane domains of the channel and to the N-terminal 'X'-domain. These linker peptides have been implicated in modulating channel physiology. Such extended constructs have proven difficult to express in bacteria, but the protein described here is stable and monomeric. Isothermal titration calorimetry reveals that glutamate binding to the domain involves a substantial heat capacity change and that at physiological temperatures, the reaction is both entropically and enthalpically favorable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866833     DOI: 10.1046/j.1432-1033.2000.01481.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Hydrophobic side chain dynamics of a glutamate receptor ligand binding domain.

Authors:  Alexander S Maltsev; Robert E Oswald
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

2.  Dynamics of cleft closure of the GluA2 ligand-binding domain in the presence of full and partial agonists revealed by hydrogen-deuterium exchange.

Authors:  Ahmed H Ahmed; Christopher P Ptak; Michael K Fenwick; Ching-Lin Hsieh; Gregory A Weiland; Robert E Oswald
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

3.  NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.

Authors:  Michael K Fenwick; Robert E Oswald
Journal:  J Mol Biol       Date:  2008-03-14       Impact factor: 5.469

4.  The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.

Authors:  Sandra M Holley; Ahmed H Ahmed; Jayasri Srinivasan; Swetha E Murthy; Gregory A Weiland; Robert E Oswald; Linda M Nowak
Journal:  Biochemistry       Date:  2012-05-02       Impact factor: 3.162

5.  Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain.

Authors:  Ahmed H Ahmed; Melissa D Thompson; Michael K Fenwick; Bethsabe Romero; Adrienne P Loh; David E Jane; Holger Sondermann; Robert E Oswald
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

6.  Glutamate binding and conformational flexibility of ligand-binding domains are critical early determinants of efficient kainate receptor biogenesis.

Authors:  Martin B Gill; Pornpun Vivithanaporn; Geoffrey T Swanson
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

7.  Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors.

Authors:  Anders S Kristensen; Kasper B Hansen; Peter Naur; Lars Olsen; Natalie L Kurtkaya; Shashank M Dravid; Trine Kvist; Feng Yi; Jacob Pøhlsgaard; Rasmus P Clausen; Michael Gajhede; Jette S Kastrup; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-12-10       Impact factor: 4.436

8.  Domain architecture of a calcium-permeable AMPA receptor in a ligand-free conformation.

Authors:  Charles R Midgett; Avinash Gill; Dean R Madden
Journal:  Front Mol Neurosci       Date:  2012-01-02       Impact factor: 5.639

9.  Thermodynamics and mechanism of the interaction of willardiine partial agonists with a glutamate receptor: implications for drug development.

Authors:  Madeline Martinez; Ahmed H Ahmed; Adrienne P Loh; Robert E Oswald
Journal:  Biochemistry       Date:  2014-06-05       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.